DMEQ-TAD

CAS: 132788-52-4

Ref. 3D-FD22574

Produktinformation

• Name: DMEQ-TAD
• Synonyme: 4-[2-(3,4-Dihydro-6,7-dimethoxy-4-methyl-3-oxo-2-quinoxalinyl)ethyl]-3H-1,2,4-triazole-3,5(4H)-dione, 4-(2-(6,7-Dimethoxy-4-Methyl-3-Oxo-3,4-Dihydroquinoxalinyl)Ethyl)-1,2,4-Triazoline-3,5-Dione, 4-[2-(6,7-dimethoxy-4-methyl-3-oxo-3,4-dihydroquinoxalin-2-yl)ethyl]-3H-1,2,4-triazole-3,5(4H)-dione
• CAS: 132788-52-4

Beschreibung

DMEQ-TAD is a synthetic molecule that can be used in clinical studies for the treatment of acute lymphoblastic leukemia. It is a fluorimetric compound with a molecular weight of 372.5 Da, which was synthesized and characterized using synthetic methods. DMEQ-TAD has been shown to inhibit the proliferation of leukemic cells in vitro and has been shown to have anti-inflammatory properties.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 345.31 g/mol
• Formel: C₁₅H₁₅N₅O₅
• Reinheit: Min. 95%
• Farbe/Form: Purple Powder
• InChl: InChI=1S/C15H15N5O5/c1-19-10-7-12(25-3)11(24-2)6-9(10)16-8(13(19)21)4-5-20-14(22)17-18-15(20)23/h6-7H,4-5H2,1-3H3
• InChI Key: InChIKey=NPKSULYVSICWLD-UHFFFAOYSA-N
• SMILES: COc1cc2nc(CCN3C(=O)N=NC3=O)c(=O)n(C)c2cc1OC